-
HOOKIPA Pharma (HOOK) Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer
-
HOOKIPA Pharma (HOOK) to Present Strong Preclinical HB-700 Dataset
-
HOOKIPA Pharma (HOOK) Announces Board of Directors Changes
-
HOOKIPA Pharma Inc. (HOOK) Announces Leadership Changes to Intensify Focus on HB-200
-
HOOKIPA Pharma Inc. (HOOK) Announces Effective Date of 1-for-10 Reverse Stock Split
-
HOOKIPA Pharma (HOOK) Doses First Person in Phase 1b Clinical Trial of HB-500

